Recent advances in understanding and managing aortic stenosis.
Mathias Van HemelrijckMaurizio TaramassoCarlotta De CarloShingo KuwataEvelyn RegarFabian NietlispachAdolfo FerreroAlberto WeberFrancesco MaisanoPublished in: F1000Research (2018)
Over the last few years, treatment of severe symptomatic aortic stenosis in high-risk patients has drastically changed to adopt a less-invasive approach. Transcatheter aortic valve implantation (TAVI) has been developed as a very reproducible and safe procedure, as shown in many trials. When compared to surgery, TAVI has produced superior, or at least comparable, results, and thus a trend to broaden treatment indications to lower-risk patients has erupted as a natural consequence, even though there is a lack of long-term evidence. In this review, we summarize and underline aspects that still remain unanswered that are compulsory if we want to enhance our understanding of this disease.
Keyphrases
- aortic stenosis
- ejection fraction
- transcatheter aortic valve implantation
- aortic valve replacement
- transcatheter aortic valve replacement
- aortic valve
- end stage renal disease
- left ventricular
- chronic kidney disease
- newly diagnosed
- minimally invasive
- prognostic factors
- heart failure
- peritoneal dialysis
- atrial fibrillation
- drug induced